A Safety Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Non-small Cell Lung Cancer
Status:
Withdrawn
Trial end date:
2019-09-29
Target enrollment:
Participant gender:
Summary
A Study to Evaluate Safety in Participants with Chemotherapy-naïve Stage IV or Recurrent
Non-small Cell Lung Cancer Treated With Nivolumab in Combination with Ipilimumab